Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Cathie Wood's ARK Investment bought 82K shares of Rocket Lab today  20:06
10/04/22
10/04
20:06
10/04/22
20:06
RKLB

Rocket Lab

$4.62 /

+0.31 (+7.19%)

 
ShowHide Related Items >><<
RKLB Rocket Lab
$4.62 /

+0.31 (+7.19%)

RKLB Rocket Lab
$4.62 /

+0.31 (+7.19%)

09/13/22 Deutsche Bank
Rocket Lab named short-term idea at Deutsche Bank
08/31/22 Cowen
Rocket Lab upgraded to Outperform from Market Perform at Cowen
08/17/22 Stifel
Rocket Lab price target lowered to $15 from $18 at Stifel
08/15/22 Deutsche Bank
Rocket Lab price target raised to $15 from $14 at Deutsche Bank
RKLB Rocket Lab
$4.62 /

+0.31 (+7.19%)

RKLB Rocket Lab
$4.62 /

+0.31 (+7.19%)

RKLB Rocket Lab
$4.62 /

+0.31 (+7.19%)

RKLB Rocket Lab
$4.62 /

+0.31 (+7.19%)

Sunday
Hot Stocks
Fly Intel: Top five weekend stock stories » 20:04
10/02/22
10/02
20:04
10/02/22
20:04
TSLA

Tesla

$265.28 /

-3 (-1.12%)

, MRNA

Moderna

$118.16 /

+0.025 (+0.02%)

, BNTX

BioNTech

$134.77 /

+1.27 (+0.95%)

, PFE

Pfizer

$43.83 /

-0.35 (-0.79%)

, OWL

Blue Owl Capital

$9.22 /

-0.06 (-0.65%)

, CHPT

ChargePoint

$14.78 /

-0.15 (-1.00%)

, LAZR

Luminar

$7.29 /

-0.08 (-1.09%)

, RKLB

Rocket Lab

$4.08 /

-0.075 (-1.81%)

, VCSA

Vacasa

$3.07 /

-0.04 (-1.29%)

, SEAT

Vivid Seats

$7.67 /

+0.08 (+1.05%)

, PARA

Paramount

$19.05 /

+0.11 (+0.58%)

, OLPX

Olaplex Holdings

$9.55 /

-0.07 (-0.73%)

, DPSGY

Deutsche Post

$30.06 /

+0.28 (+0.94%)

Catch up on the…

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Tesla (TSLA) reported Q3 deliveries of 343,830, with 3% subject to operating lease accounting, and production of 365,923 vehicles. Tesla delivered 18,672 Model S/X and 325,158 Model 3/Y. The company said that, "Historically, our delivery volumes have skewed towards the end of each quarter due to regional batch building of cars. As our production volumes continue to grow, it is becoming increasingly challenging to secure vehicle transportation capacity and at a reasonable cost during these peak logistics weeks. In Q3, we began transitioning to a more even regional mix of vehicle builds each week, which led to an increase in cars in transit at the end of the quarter. These cars have been ordered and will be delivered to customers upon arrival at their destination." 2. Moderna (MRNA) has refused to hand over to China the core intellectual property behind the development of its breakthrough COVID-19 vaccine, leading to a collapse in negotiations on its sale there, Financial Times; Sun Yu, Eleanor Olcott and Donato Paolo Mancini report, citing people familiar with the matter. The company turned down Beijing's request to hand over the recipe for its messenger RNA vaccine because of commercial and safety concerns, said two people involved in negotiations that took place between 2020 and 2021. The vaccine maker says it is still "eager" to sell the product to China, the authors wrote. The mRNA vaccine technology used by Moderna and BioNTech (BTNX)/Pfizer (PFE) provides longer-lasting and higher levels of protection than the inactivated vaccine technology used by Chinese makers. Several Chinese pharma companies are racing to develop a homemade mRNA alternative but have struggled with the emergence of more infectious variants, the publication adds. 3. One year ago, investors couldn't get enough of special-purpose acquisition companies. Now, they can't dump SPACs fast enough, Al Root writes in this week's edition of Barron's. New technologies, new capital, and optimistic business projections had investors dreaming of big gains from these blank-check companies, like the 250% pop in 2020. Now that bubble has popped, the author notes. Many of the stocks got what they deserved after offering financial guidance that has proven wildly off the mark, but not every company has failed so spectacularly, the publication adds. Many look like solid companies that made the bad choice of coming to market via a SPAC, the author writes, such as Blue Owl Capital (OWL), ChargePoint (CHPT), Luminar (LAZR), Rocket Lab (RKLB), Vacasa (VCSA), and Vivid Seats (SEAT). 4. Paramount's (PARA) horror movie "Smile" on the weekend at the North America box office with a $22M debut from 3,645 locations. The film tells the story of a therapist who meets a graduate student who recently witnesses a gruesome suicide. Jessie T. Usher Kyle Gallner, Robin Weigert and Kal Penn co-star. 5. Olaplex Holdings (OLPX) and Deutsche Post DHL Group (DPSGY) saw positive mentions in this week's edition of Barron's.

ShowHide Related Items >><<
VCSA Vacasa
$3.07 /

-0.04 (-1.29%)

TSLA Tesla
$265.28 /

-3 (-1.12%)

SEAT Vivid Seats
$7.67 /

+0.08 (+1.05%)

RKLB Rocket Lab
$4.08 /

-0.075 (-1.81%)

PFE Pfizer
$43.83 /

-0.35 (-0.79%)

PARA Paramount
$19.05 /

+0.11 (+0.58%)

OWL Blue Owl Capital
$9.22 /

-0.06 (-0.65%)

OLPX Olaplex Holdings
$9.55 /

-0.07 (-0.73%)

MRNA Moderna
$118.16 /

+0.025 (+0.02%)

LAZR Luminar
$7.29 /

-0.08 (-1.09%)

CHPT ChargePoint
$14.78 /

-0.15 (-1.00%)

BNTX BioNTech
$134.77 /

+1.27 (+0.95%)

TSLA Tesla
$265.28 /

-3 (-1.12%)

09/30/22 Morgan Stanley
U.S. recession, 'Tesla-friendly' IRA may force change at GM, says Morgan Stanley
09/29/22 Piper Sandler
Piper cuts Tesla target, says Q3 deliver estimates 'probably too high'
09/28/22 Citi
Citi lowers Q3 deliveries estimate for Tesla, sees risk to Q4 numbers
09/20/22 Morgan Stanley
Tesla passing through 'peak China' dependency stage, says Morgan Stanley
MRNA Moderna
$118.16 /

+0.025 (+0.02%)

09/14/22 Argus
Moderna price target lowered to $150 from $180 at Argus
09/07/22 Deutsche Bank
Moderna upgraded to Buy with $165 target at Deutsche Bank
09/07/22 Deutsche Bank
Moderna upgraded to Buy from Hold at Deutsche Bank
09/02/22 Cantor Fitzgerald
Cantor says ACIP recommendations support 'continued tail' for COVID-19 vaccines
BNTX BioNTech
$134.77 /

+1.27 (+0.95%)

08/17/22 Cowen
BioNTech initiated with a Market Perform at Cowen
08/10/22 H.C. Wainwright
BioNTech price target lowered to $272 from $283 at H.C. Wainwright
PFE Pfizer
$43.83 /

-0.35 (-0.79%)

09/20/22 Citi
Citi opens 'upside catalyst watch' on Alnylam Pharmaceuticals
09/13/22 Truist
Concert Pharmaceuticals price target raised to $25 from $22 at Truist
08/26/22 Citi
Citi opens 'positive catalyst watches' on GSK, Sanofi after Zantac ruling
OWL Blue Owl Capital
$9.22 /

-0.06 (-0.65%)

09/12/22 Deutsche Bank
Blue Owl Capital initiated with a Buy at Deutsche Bank
07/11/22 JPMorgan
Blue Owl Capital initiated with a Neutral at JPMorgan (Thursday)
06/08/22 JMP Securities
Blue Owl Capital initiated with an Outperform at JMP Securities
01/24/22 BofA
Blue Owl Capital initiated with a Buy at BofA
CHPT ChargePoint
$14.78 /

-0.15 (-1.00%)

09/07/22 Credit Suisse
ChargePoint initiated with an Outperform at Credit Suisse
08/31/22 Oppenheimer
ChargePoint results strong despite supply headwinds, says Oppenheimer
08/31/22 JPMorgan
ChargePoint leadership remains underappreciated, says JPMorgan
08/23/22 JPMorgan
ChargePoint price target raised to $20 from $18 at JPMorgan
LAZR Luminar
$7.29 /

-0.08 (-1.09%)

09/28/22 Berenberg
Berenberg assumes LiDAR stocks, recommends Innoviz over Luminar
09/28/22 Berenberg
Luminar assumed with a Hold at Berenberg
09/22/22 Northland
Luminar downgraded to Market Perform from Outperform at Northland
09/20/22 JPMorgan
Luminar initiated with an Overweight at JPMorgan
RKLB Rocket Lab
$4.08 /

-0.075 (-1.81%)

09/13/22 Deutsche Bank
Rocket Lab named short-term idea at Deutsche Bank
08/31/22 Cowen
Rocket Lab upgraded to Outperform from Market Perform at Cowen
08/17/22 Stifel
Rocket Lab price target lowered to $15 from $18 at Stifel
08/15/22 Deutsche Bank
Rocket Lab price target raised to $15 from $14 at Deutsche Bank
VCSA Vacasa
$3.07 /

-0.04 (-1.29%)

06/29/22 JPMorgan
Vacasa price target lowered to $6 from $9 at JPMorgan
06/09/22 Goldman Sachs
Vacasa price target lowered to $5.50 from $9 at Goldman Sachs
06/09/22 JMP Securities
Vacasa assumed with an Outperform at JMP Securities
03/29/22 KeyBanc
End-market data analysis suggests consumer travel holding up well, says KeyBanc
SEAT Vivid Seats
$7.67 /

+0.08 (+1.05%)

08/29/22 RBC Capital
RBC starts Vivid Seats at Sector Perform, sees position balanced by valuation
08/29/22 RBC Capital
Vivid Seats initiated with a Sector Perform at RBC Capital
08/09/22 Piper Sandler
Vivid Seats price target raised to $9 from $8 at Piper Sandler
07/14/22 Piper Sandler
Vivid Seats initiated with a Neutral at Piper Sandler
PARA Paramount
$19.05 /

+0.11 (+0.58%)

08/15/22 Benchmark
Nexstar getting 75% stake in CW Network for 'free,' says Benchmark
08/05/22 Deutsche Bank
Paramount price target lowered to $32 from $35 at Deutsche Bank
08/05/22 JPMorgan
JPMorgan downgrades Paramount to Underweight on soft DTC revenue
08/05/22 Morgan Stanley
Paramount price target lowered to $20 from $22 at Morgan Stanley
OLPX Olaplex Holdings
$9.55 /

-0.07 (-0.73%)

09/29/22 Piper Sandler
Olaplex Holdings downgraded to Neutral from Overweight at Piper Sandler
09/07/22 Piper Sandler
Olaplex Holdings price target lowered to $19 from $21 at Piper Sandler
08/10/22 Piper Sandler
Olaplex Holdings price target lowered to $21 from $24 at Piper Sandler
08/03/22 Barclays
Olaplex downgraded to Equal Weight from Overweight at Barclays
DPSGY Deutsche Post
$30.06 /

+0.28 (+0.94%)

09/30/22 Bernstein
Deutsche Post upgraded to Outperform from Market Perform at Bernstein
09/29/22 JPMorgan
Deutsche Post price target lowered to EUR 50.90 from EUR 52.50 at JPMorgan
09/20/22 Goldman Sachs
Deutsche Post downgraded to Neutral from Buy at Goldman Sachs
09/16/22 JPMorgan
Deutsche Post price target lowered to EUR 52.50 from EUR 58 at JPMorgan
VCSA Vacasa
$3.07 /

-0.04 (-1.29%)

TSLA Tesla
$265.28 /

-3 (-1.12%)

SEAT Vivid Seats
$7.67 /

+0.08 (+1.05%)

RKLB Rocket Lab
$4.08 /

-0.075 (-1.81%)

PFE Pfizer
$43.83 /

-0.35 (-0.79%)

PARA Paramount
$19.05 /

+0.11 (+0.58%)

OWL Blue Owl Capital
$9.22 /

-0.06 (-0.65%)

OLPX Olaplex Holdings
$9.55 /

-0.07 (-0.73%)

MRNA Moderna
$118.16 /

+0.025 (+0.02%)

LAZR Luminar
$7.29 /

-0.08 (-1.09%)

CHPT ChargePoint
$14.78 /

-0.15 (-1.00%)

BNTX BioNTech
$134.77 /

+1.27 (+0.95%)

  • 02
    Jun
  • 08
    Dec
TSLA Tesla
$265.28 /

-3 (-1.12%)

PFE Pfizer
$43.83 /

-0.35 (-0.79%)

PARA Paramount
$19.05 /

+0.11 (+0.58%)

OWL Blue Owl Capital
$9.22 /

-0.06 (-0.65%)

OLPX Olaplex Holdings
$9.55 /

-0.07 (-0.73%)

MRNA Moderna
$118.16 /

+0.025 (+0.02%)

LAZR Luminar
$7.29 /

-0.08 (-1.09%)

DPSGY Deutsche Post
$30.06 /

+0.28 (+0.94%)

BNTX BioNTech
$134.77 /

+1.27 (+0.95%)

VCSA Vacasa
$3.07 /

-0.04 (-1.29%)

TSLA Tesla
$265.28 /

-3 (-1.12%)

RKLB Rocket Lab
$4.08 /

-0.075 (-1.81%)

PARA Paramount
$19.05 /

+0.11 (+0.58%)

OWL Blue Owl Capital
$9.22 /

-0.06 (-0.65%)

OLPX Olaplex Holdings
$9.55 /

-0.07 (-0.73%)

MRNA Moderna
$118.16 /

+0.025 (+0.02%)

LAZR Luminar
$7.29 /

-0.08 (-1.09%)

CHPT ChargePoint
$14.78 /

-0.15 (-1.00%)

BNTX BioNTech
$134.77 /

+1.27 (+0.95%)

VCSA Vacasa
$3.07 /

-0.04 (-1.29%)

TSLA Tesla
$265.28 /

-3 (-1.12%)

RKLB Rocket Lab
$4.08 /

-0.075 (-1.81%)

PFE Pfizer
$43.83 /

-0.35 (-0.79%)

PARA Paramount
$19.05 /

+0.11 (+0.58%)

MRNA Moderna
$118.16 /

+0.025 (+0.02%)

LAZR Luminar
$7.29 /

-0.08 (-1.09%)

CHPT ChargePoint
$14.78 /

-0.15 (-1.00%)

BNTX BioNTech
$134.77 /

+1.27 (+0.95%)

Saturday
Periodicals
SPAC bubble has burst, Blue Owl Luminar still have potential, Barron's says » 09:48
10/01/22
10/01
09:48
10/01/22
09:48
OWL

Blue Owl Capital

$9.22 /

-0.06 (-0.65%)

, CHPT

ChargePoint

$14.78 /

-0.15 (-1.00%)

, LAZR

Luminar

$7.29 /

-0.08 (-1.09%)

, RKLB

Rocket Lab

$4.08 /

-0.075 (-1.81%)

, VCSA

Vacasa

$3.07 /

-0.04 (-1.29%)

, SEAT

Vivid Seats

$7.67 /

+0.08 (+1.05%)

One year ago, investors…

One year ago, investors couldn't get enough of special-purpose acquisition companies. Now, they can't dump SPACs fast enough, Al Root writes in this week's edition of Barron's. New technologies, new capital, and optimistic business projections had investors dreaming of big gains from these blank-check companies, like the 250% pop in 2020. Now that bubble has popped, the author notes. Many of the stocks got what they deserved after offering financial guidance that has proven wildly off the mark, but not every company has failed so spectacularly, the publication adds. Many look like solid companies that made the bad choice of coming to market via a SPAC, the author writes, such as Blue Owl Capital (OWL), ChargePoint (CHPT), Luminar (LAZR), Rocket Lab (RKLB), Vacasa (VCSA), and Vivid Seats (SEAT). Reference Link

ShowHide Related Items >><<
VCSA Vacasa
$3.07 /

-0.04 (-1.29%)

SEAT Vivid Seats
$7.67 /

+0.08 (+1.05%)

RKLB Rocket Lab
$4.08 /

-0.075 (-1.81%)

OWL Blue Owl Capital
$9.22 /

-0.06 (-0.65%)

LAZR Luminar
$7.29 /

-0.08 (-1.09%)

CHPT ChargePoint
$14.78 /

-0.15 (-1.00%)

OWL Blue Owl Capital
$9.22 /

-0.06 (-0.65%)

09/12/22 Deutsche Bank
Blue Owl Capital initiated with a Buy at Deutsche Bank
07/11/22 JPMorgan
Blue Owl Capital initiated with a Neutral at JPMorgan (Thursday)
06/08/22 JMP Securities
Blue Owl Capital initiated with an Outperform at JMP Securities
01/24/22 BofA
Blue Owl Capital initiated with a Buy at BofA
CHPT ChargePoint
$14.78 /

-0.15 (-1.00%)

09/07/22 Credit Suisse
ChargePoint initiated with an Outperform at Credit Suisse
08/31/22 Oppenheimer
ChargePoint results strong despite supply headwinds, says Oppenheimer
08/31/22 JPMorgan
ChargePoint leadership remains underappreciated, says JPMorgan
08/23/22 JPMorgan
ChargePoint price target raised to $20 from $18 at JPMorgan
LAZR Luminar
$7.29 /

-0.08 (-1.09%)

09/28/22 Berenberg
Berenberg assumes LiDAR stocks, recommends Innoviz over Luminar
09/28/22 Berenberg
Luminar assumed with a Hold at Berenberg
09/22/22 Northland
Luminar downgraded to Market Perform from Outperform at Northland
09/20/22 JPMorgan
Luminar initiated with an Overweight at JPMorgan
RKLB Rocket Lab
$4.08 /

-0.075 (-1.81%)

09/13/22 Deutsche Bank
Rocket Lab named short-term idea at Deutsche Bank
08/31/22 Cowen
Rocket Lab upgraded to Outperform from Market Perform at Cowen
08/17/22 Stifel
Rocket Lab price target lowered to $15 from $18 at Stifel
08/15/22 Deutsche Bank
Rocket Lab price target raised to $15 from $14 at Deutsche Bank
VCSA Vacasa
$3.07 /

-0.04 (-1.29%)

06/29/22 JPMorgan
Vacasa price target lowered to $6 from $9 at JPMorgan
06/09/22 Goldman Sachs
Vacasa price target lowered to $5.50 from $9 at Goldman Sachs
06/09/22 JMP Securities
Vacasa assumed with an Outperform at JMP Securities
03/29/22 KeyBanc
End-market data analysis suggests consumer travel holding up well, says KeyBanc
SEAT Vivid Seats
$7.67 /

+0.08 (+1.05%)

08/29/22 RBC Capital
RBC starts Vivid Seats at Sector Perform, sees position balanced by valuation
08/29/22 RBC Capital
Vivid Seats initiated with a Sector Perform at RBC Capital
08/09/22 Piper Sandler
Vivid Seats price target raised to $9 from $8 at Piper Sandler
07/14/22 Piper Sandler
Vivid Seats initiated with a Neutral at Piper Sandler
VCSA Vacasa
$3.07 /

-0.04 (-1.29%)

SEAT Vivid Seats
$7.67 /

+0.08 (+1.05%)

RKLB Rocket Lab
$4.08 /

-0.075 (-1.81%)

OWL Blue Owl Capital
$9.22 /

-0.06 (-0.65%)

LAZR Luminar
$7.29 /

-0.08 (-1.09%)

CHPT ChargePoint
$14.78 /

-0.15 (-1.00%)

  • 02
    Jun
  • 08
    Dec
OWL Blue Owl Capital
$9.22 /

-0.06 (-0.65%)

LAZR Luminar
$7.29 /

-0.08 (-1.09%)

VCSA Vacasa
$3.07 /

-0.04 (-1.29%)

RKLB Rocket Lab
$4.08 /

-0.075 (-1.81%)

OWL Blue Owl Capital
$9.22 /

-0.06 (-0.65%)

LAZR Luminar
$7.29 /

-0.08 (-1.09%)

CHPT ChargePoint
$14.78 /

-0.15 (-1.00%)

VCSA Vacasa
$3.07 /

-0.04 (-1.29%)

RKLB Rocket Lab
$4.08 /

-0.075 (-1.81%)

LAZR Luminar
$7.29 /

-0.08 (-1.09%)

CHPT ChargePoint
$14.78 /

-0.15 (-1.00%)

Thursday
Hot Stocks
Cathie Wood's ARK Investment bought 141.5K shares of Rocket Lab today  20:45
09/29/22
09/29
20:45
09/29/22
20:45
RKLB

Rocket Lab

$4.16 /

-0.23 (-5.25%)

 
ShowHide Related Items >><<
RKLB Rocket Lab
$4.16 /

-0.23 (-5.25%)

RKLB Rocket Lab
$4.16 /

-0.23 (-5.25%)

09/13/22 Deutsche Bank
Rocket Lab named short-term idea at Deutsche Bank
08/31/22 Cowen
Rocket Lab upgraded to Outperform from Market Perform at Cowen
08/17/22 Stifel
Rocket Lab price target lowered to $15 from $18 at Stifel
08/15/22 Deutsche Bank
Rocket Lab price target raised to $15 from $14 at Deutsche Bank
RKLB Rocket Lab
$4.16 /

-0.23 (-5.25%)

RKLB Rocket Lab
$4.16 /

-0.23 (-5.25%)

RKLB Rocket Lab
$4.16 /

-0.23 (-5.25%)

Over a week ago
Hot Stocks
Cathie Wood's ARK Investment bought 221K shares of Rocket Lab today  20:33
09/27/22
09/27
20:33
09/27/22
20:33
RKLB

Rocket Lab

$4.19 /

-0.045 (-1.06%)

 
ShowHide Related Items >><<
RKLB Rocket Lab
$4.19 /

-0.045 (-1.06%)

RKLB Rocket Lab
$4.19 /

-0.045 (-1.06%)

09/13/22 Deutsche Bank
Rocket Lab named short-term idea at Deutsche Bank
08/31/22 Cowen
Rocket Lab upgraded to Outperform from Market Perform at Cowen
08/17/22 Stifel
Rocket Lab price target lowered to $15 from $18 at Stifel
08/15/22 Deutsche Bank
Rocket Lab price target raised to $15 from $14 at Deutsche Bank
RKLB Rocket Lab
$4.19 /

-0.045 (-1.06%)

RKLB Rocket Lab
$4.19 /

-0.045 (-1.06%)

RKLB Rocket Lab
$4.19 /

-0.045 (-1.06%)

Hot Stocks
Cathie Wood's ARK Investment bought 508K shares of Rocket Lab today  20:11
09/26/22
09/26
20:11
09/26/22
20:11
RKLB

Rocket Lab

$4.24 /

+0.115 (+2.79%)

 
ShowHide Related Items >><<
RKLB Rocket Lab
$4.24 /

+0.115 (+2.79%)

RKLB Rocket Lab
$4.24 /

+0.115 (+2.79%)

09/13/22 Deutsche Bank
Rocket Lab named short-term idea at Deutsche Bank
08/31/22 Cowen
Rocket Lab upgraded to Outperform from Market Perform at Cowen
08/17/22 Stifel
Rocket Lab price target lowered to $15 from $18 at Stifel
08/15/22 Deutsche Bank
Rocket Lab price target raised to $15 from $14 at Deutsche Bank
RKLB Rocket Lab
$4.24 /

+0.115 (+2.79%)

RKLB Rocket Lab
$4.24 /

+0.115 (+2.79%)

RKLB Rocket Lab
$4.24 /

+0.115 (+2.79%)

Conference/Events
Rocket Lab to hold an investor day » 12:32
09/21/22
09/21
12:32
09/21/22
12:32
RKLB

Rocket Lab

$5.07 /

+0.03 (+0.60%)

Investor Day and Neutron…

Investor Day and Neutron launch vehicle development update in New York on September 21 at 1:30 pm. Webcast Link

ShowHide Related Items >><<
RKLB Rocket Lab
$5.07 /

+0.03 (+0.60%)

RKLB Rocket Lab
$5.07 /

+0.03 (+0.60%)

09/13/22 Deutsche Bank
Rocket Lab named short-term idea at Deutsche Bank
08/31/22 Cowen
Rocket Lab upgraded to Outperform from Market Perform at Cowen
08/17/22 Stifel
Rocket Lab price target lowered to $15 from $18 at Stifel
08/15/22 Deutsche Bank
Rocket Lab price target raised to $15 from $14 at Deutsche Bank
RKLB Rocket Lab
$5.07 /

+0.03 (+0.60%)

RKLB Rocket Lab
$5.07 /

+0.03 (+0.60%)

RKLB Rocket Lab
$5.07 /

+0.03 (+0.60%)

Hot Stocks
Rocket Lab selects NASA Stennis Space Center for neutron engine test facility » 07:32
09/21/22
09/21
07:32
09/21/22
07:32
RKLB

Rocket Lab

$5.05 /

-0.025 (-0.49%)

Rocket Lab USA revealed…

Rocket Lab USA revealed it has selected NASA's historic Stennis Space Center in Mississippi as the location of its engine test facility for its reusable rocket, Neutron. The Archimedes Test Complex will be located within the larger A Test Complex at Stennis Space Center across a 1 million square foot area for 10 years, with an option to extend the lease for an additional 10 years. The Archimedes Test Complex will include exclusive use and development of existing industrial NASA infrastructure and the Center's A-3 Test Stand to develop and test Neutron's Archimedes reusable engines. Rocket Lab has also secured a capital investment incentive from the Mississippi Development Authority to further develop the facilities and infrastructure at Stennis for Neutron. By expanding Stennis Space Center to include the Archimedes Test Complex, Rocket Lab is expected to create dozens of new jobs and make significant capital investments in the state of Mississippi.

ShowHide Related Items >><<
RKLB Rocket Lab
$5.05 /

-0.025 (-0.49%)

RKLB Rocket Lab
$5.05 /

-0.025 (-0.49%)

09/13/22 Deutsche Bank
Rocket Lab named short-term idea at Deutsche Bank
08/31/22 Cowen
Rocket Lab upgraded to Outperform from Market Perform at Cowen
08/17/22 Stifel
Rocket Lab price target lowered to $15 from $18 at Stifel
08/15/22 Deutsche Bank
Rocket Lab price target raised to $15 from $14 at Deutsche Bank
RKLB Rocket Lab
$5.05 /

-0.025 (-0.49%)

RKLB Rocket Lab
$5.05 /

-0.025 (-0.49%)

RKLB Rocket Lab
$5.05 /

-0.025 (-0.49%)

Hot Stocks
Rocket Lab to launch dedicated Electron mission for GA-EMS » 07:34
09/19/22
09/19
07:34
09/19/22
07:34
RKLB

Rocket Lab

$5.03 /

-0.065 (-1.28%)

Rocket Lab announced that…

Rocket Lab announced that it will launch a dedicated Electron mission for General Atomics Electromagnetic Systems, or GA-EMS. Electron is scheduled to launch the "It Argos Up From Here" mission from Rocket Lab Launch Complex 1 in Mahia, New Zealand during a launch window that opens October 5. The "It Argos Up From Here" mission will launch the GA-EMS designed and manufactured satellite carrying the A-DCS hosted payload. The A-DCS mission is supported by the National Oceanic and Atmospheric Administration, or NOAA, Cooperative Data and Rescue Services Program, which arranged the launch through the Hosted Payload Solutions contract vehicle administered by the U.S. Space Force's Space Systems Command.

ShowHide Related Items >><<
RKLB Rocket Lab
$5.03 /

-0.065 (-1.28%)

RKLB Rocket Lab
$5.03 /

-0.065 (-1.28%)

09/13/22 Deutsche Bank
Rocket Lab named short-term idea at Deutsche Bank
08/31/22 Cowen
Rocket Lab upgraded to Outperform from Market Perform at Cowen
08/17/22 Stifel
Rocket Lab price target lowered to $15 from $18 at Stifel
08/15/22 Deutsche Bank
Rocket Lab price target raised to $15 from $14 at Deutsche Bank
RKLB Rocket Lab
$5.03 /

-0.065 (-1.28%)

RKLB Rocket Lab
$5.03 /

-0.065 (-1.28%)

RKLB Rocket Lab
$5.03 /

-0.065 (-1.28%)

Hot Stocks
Rocket Lab exec sells $1.13M in common stock » 19:30
09/15/22
09/15
19:30
09/15/22
19:30
RKLB

Rocket Lab

$5.10 /

-0.605 (-10.61%)

In a regulatory filing,…

In a regulatory filing, Rocket Lab disclosed that its EVP Shaun O'Donnell sold 200K shares of common stock on September 13th in a total transaction size of $1.13M.

ShowHide Related Items >><<
RKLB Rocket Lab
$5.10 /

-0.605 (-10.61%)

RKLB Rocket Lab
$5.10 /

-0.605 (-10.61%)

09/13/22 Deutsche Bank
Rocket Lab named short-term idea at Deutsche Bank
08/31/22 Cowen
Rocket Lab upgraded to Outperform from Market Perform at Cowen
08/17/22 Stifel
Rocket Lab price target lowered to $15 from $18 at Stifel
08/15/22 Deutsche Bank
Rocket Lab price target raised to $15 from $14 at Deutsche Bank
RKLB Rocket Lab
$5.10 /

-0.605 (-10.61%)

RKLB Rocket Lab
$5.10 /

-0.605 (-10.61%)

RKLB Rocket Lab
$5.10 /

-0.605 (-10.61%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.